as 12-20-2024 4:00pm EST
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
Founded: | 1994 | Country: | United States |
Employees: | N/A | City: | WIXOM |
Market Cap: | 72.7M | IPO Year: | 1998 |
Target Price: | $6.00 | AVG Volume (30 days): | 660.2K |
Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.05 | EPS Growth: | N/A |
52 Week Low/High: | $1.16 - $5.15 | Next Earning Date: | 11-12-2024 |
Revenue: | $98,917,000 | Revenue Growth: | 22.37% |
Revenue Growth (this year): | 22.58% | Revenue Growth (next year): | -17.21% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
RAVICH MARK H | RMTI | Director | Nov 15 '24 | Sell | $2.36 | 29,991 | $70,379.12 | 121,429 | |
Strobeck Mark | RMTI | President and CEO | Oct 1 '24 | Sell | $3.69 | 2,163 | $7,971.09 | 147,201 | |
Chole Timothy | RMTI | SVP, Chief Commercial Officer | Oct 1 '24 | Sell | $3.69 | 1,001 | $3,688.89 | 55,171 |
RMTI Breaking Stock News: Dive into RMTI Ticker-Specific Updates for Smart Investing
Benzinga
6 days ago
Business Wire
6 days ago
Business Wire
11 days ago
Business Wire
18 days ago
Business Wire
a month ago
Simply Wall St.
a month ago
Simply Wall St.
a month ago
GuruFocus.com
a month ago
The information presented on this page, "RMTI Rockwell Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.